Methylphenidate Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00422 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 23 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | faciodigitogenital syndrome | KG + DL |
| 2 | chondromyxoid fibroma | KG + DL |
| 3 | specific developmental disorder | KG + DL |
| 4 | dysthymic disorder | KG + DL |
| 5 | trichotillomania | KG + DL |
| 6 | cerebellar ataxia | KG + DL |
| 7 | autosomal dominant cerebellar ataxia | KG + DL |
| 8 | spinocerebellar degeneration with slow eye movements | KG + DL |
| 9 | benign paroxysmal torticollis of infancy | KG + DL |
| 10 | insomnia (disease) | KG + DL |
| 11 | transient tic disorder | KG + DL |
| 12 | anxiety disorder | KG + DL |
| 13 | hypersomnia (disease) | KG + DL |
| 14 | agoraphobia | KG + DL |
| 15 | circadian rhythm sleep disorder | KG + DL |
| 16 | narcolepsy, susceptibility to | KG + DL |
| 17 | Creutzfeldt-Jakob disease | KG + DL |
| 18 | manic bipolar affective disorder | KG + DL |
| 19 | disorder of peroxisomal alpha-, beta- and omega-oxidation | KG + DL |
| 20 | ACBD5 deficiency | KG + DL |
| 21 | narcolepsy without cataplexy | KG + DL |
| 22 | obsessive-compulsive disorder | KG + DL |
| 23 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.